J. van Nagell

476 total citations
11 papers, 337 citations indexed

About

J. van Nagell is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, J. van Nagell has authored 11 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Reproductive Medicine, 4 papers in Obstetrics and Gynecology and 3 papers in Surgery. Recurrent topics in J. van Nagell's work include Ovarian cancer diagnosis and treatment (8 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Cancer Genomics and Diagnostics (2 papers). J. van Nagell is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Endometrial and Cervical Cancer Treatments (4 papers) and Cancer Genomics and Diagnostics (2 papers). J. van Nagell collaborates with scholars based in United States, Sweden and France. J. van Nagell's co-authors include Frederick R. Ueland, Deborah E. Powell, Larry E. Puls, Richard J. Kryscio, Paul D. DePriest, Robert V. Higgins, Susan C. Modesitt, Christina Chu, Matthew A. Powell and Karen H. Lu and has published in prestigious journals such as Human Pathology, Gynecologic Oncology and International Journal of Gynecological Cancer.

In The Last Decade

J. van Nagell

10 papers receiving 324 citations

Peers

Countries citing papers authored by J. van Nagell

Since Specialization

Citations

This map shows the geographic impact of J. van Nagell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. van Nagell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. van Nagell more than expected).

Fields of papers citing papers by J. van Nagell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. van Nagell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. van Nagell. The network helps show where J. van Nagell may publish in the future.

Co-authorship network of co-authors of J. van Nagell

This figure shows the co-authorship network connecting the top 25 collaborators of J. van Nagell. A scholar is included among the top collaborators of J. van Nagell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. van Nagell. J. van Nagell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Complications from Surgeries Related to Ovarian Cancer Screening 2017 ·Diagnostics ·Lauren Baldwin, Edward J. Pavlik, (unknown), Hannah Brown, (unknown), Bin Huang, Christopher P. DeSimone, J. van Nagell, Frederick R. Ueland, Rachel Miller	6
2	Endometrial cancer lesion size is predictive of disease recurrence and long-term survival 2013 ·Gynecologic Oncology ·(unknown), Jeffrey Elder, Alexandra Edwards, Stacey Slone, Jonathan Feddock, Rachel W. Miller, Lauren Baldwin, J. van Nagell, Frederick R. Ueland	1
3	Monitoring ovarian tumors using serial ultrasound with tumor morphology index 2013 ·Gynecologic Oncology ·Jeffrey Elder, (unknown), Rachel W. Miller, (unknown), (unknown), John Hoff, Richard J. Kryscio, J. van Nagell, Edward J. Pavlik, F. Ueland	1
4	Ten-year relative survival for epithelial ovarian cancer 2011 ·Gynecologic Oncology ·Lauren Baldwin, Rachel Ware, Binhao Huang, (unknown), S. Goodrich, Iwona Podzielinski, (unknown), F. Ueland, J. van Nagell, Leigh G. Seamon	16
5	Testosterone Treatment in Women – An Overview 2009 ·Current Women s Health Reviews ·Amy Cooper, (unknown), (unknown), Frederick R. Ueland, Christopher P. DeSimone, Paul D. DePriest, John McDonald, (unknown), Rachel Ware, Edward J. Pavlik, Richard J. Kryscio, Michael Karpf, J. van Nagell, Angelique Flöter Rådestad	7
6	Long-Term Survival and Cost of Treatment in Patients with Stage IIIC Epithelial Ovarian Cancer 2009 ·Current Women s Health Reviews ·(unknown), C. Sifer, Amy Cooper, David Nelson, (unknown), Frederick R. Ueland, Christopher P. DeSimone, Paul D. DePriest, John McDonald, (unknown), Rachel Ware, Edward J. Pavlik, Richard J. Kryscio, Michael Karpf, J. van Nagell	11
7	Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation☆ 2003 ·Gynecologic Oncology ·James L. Wilder, Edward J. Pavlik, J. Michael Straughn, Tyler O. Kirby, Robert V. Higgins, Paul D. DePriest, Frederick R. Ueland, Richard J. Kryscio, Ronald J. Whitley, J. van Nagell	57
8	Outcome of Reproductive Age Women with Stage IA or IC Invasive Epithelial Ovarian Cancer Treated with Fertility-Sparing Therapy 2002 ·Gynecologic Oncology ·Jeanne M. Schilder, Amy Thompson, Paul D. DePriest, Frederick R. Ueland, Michael L. Cibull, Richard J. Kryscio, Susan C. Modesitt, Karen H. Lu, John P. Geisler, Robert V. Higgins, Paul M. Magtibay, David E. Cohn, Matthew A. Powell, Christina Chu, Frederick B. Stehman, J. van Nagell	179
9	Lymphvascular invasion in stage IB cervical carcinoma: prognostic significance and role of adjuvant radiotherapy 1996 ·International Journal of Gynecological Cancer ·Patrick Francke, Yūji Maruyama, J. van Nagell, Paul D. DePriest	0
10	Current concepts in epithelial ovarian tumors: Does benign to malignant transformation occur? 1992 ·Human Pathology ·Deborah E. Powell, Larry E. Puls, J. van Nagell	54
11	Histocompatibility-antigen distribution in patients with cervical and endometrial carcinomas 1981 ·Gynecologic Oncology ·Irena Sniecinski, John V. Haley, (unknown), J. van Nagell	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact